Demographic and clinical characteristics (n=40)
| Characteristic | Total n=40 |
| Country, n (%) | |
| USA | 7 (17.5) |
| Canada | 9 (22.5) |
| UK | 9 (22.5) |
| Germany | 4 (10.0) |
| Spain | 3 (7.5) |
| Brazil | 2 (5.0) |
| Japan | 6 (15.0) |
| Age (years), mean (SD) | 58.4 (9.9) |
| Male, n (%) | 22 (55.0) |
| Education (years), mean (SD) | 14.3 (2.5) |
| Employment status at survey completion, n (%) | |
| Working full-time | 13 (32.5) |
| Working part-time | 5 (12.5) |
| On sick/disability leave from work | 3 (7.5) |
| Not employed | 4 (10.0) |
| Retired | 15 (37.5) |
| Years since first diabetes diagnosis to basal insulin initiation, mean (SD) | 11.2 (7.7) |
| HbA1c (%) before insulin initiation, mean (SD)* | 9.9 (2.9) |
| HbA1c (mmol/mol) before insulin initiation, mean (SD)* | 84.7 (31.2) |
| HbA1c (%) current, mean (SD)* | 8.3 (2.7) |
| HbA1c (mol/mol) current, mean (SD)* | 67.7 (31.0) |
| BMI before insulin initiation (kg/m2)/Current BMI | |
| Mean (SD) | 31.7/31.8 (7.8/7.0) |
| <18.5, n (%) | 1/0 (2.5%/0.0%) |
| 18.5–24.9, n (%) | 5/4 (12.5%/10.0%) |
| 25.0–29.9, n (%) | 13/16 (32.5%/40.0%) |
| ≥30.0, n (%) | 21/20 (52.5%/50.0%) |
*Mean HbA1c was calculated among the patients with a self-reported known test result (n=23 before insulin initiation and n=29 for most recent result within a year before survey).
BMI, body mass index; HbA1c, Hemoglobin A1c; SD, standard deviation.